SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (105)3/14/2001 12:18:05 PM
From: nigel bates  Respond to of 469
 
CAT already lost around 30% in the last few days. I did sell a few to buy some ABGX (just before ABGX lost around 30%...).

I'm hesitant to sell OGS at current levels, not having done so a couple of weeks ago - & who would you switch into ?

nig



To: keokalani'nui who wrote (105)3/14/2001 1:14:52 PM
From: nigel bates  Read Replies (1) | Respond to of 469
 
...and which of the US 'proteomics' companies have a pipeline as far advanced as OGS ?
...although several, admittedly, are trading at less than 1.5x cash.

nig


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News